Potentially pathogenic variants identified in the patients included in the study
Samples | Potentially Pathogenic Variants | State of Variants | Inheritance | Refs. | Prediction of Pathogenicity of Variants | ||
---|---|---|---|---|---|---|---|
In Silico Analysis | AA Conservation among Species | ||||||
PolyPhen | PMut | ||||||
Patient 1 | NPHS2 c.[-52C>G]+[-52C>G] | Homozygous | AR | Oleggini et al.16 | |||
Patient 2 | NPHS2 c.[419delG]+[419delG]; p.[Gly140Aspfs*41]+[Gly140Aspfs*41] | Homozygous | AR | Boute et al.17 | |||
Patient 3 | NPHS2 c.[413G>A]+[467_468insT]; p.[Arg138Gln]+[Leu156Phefs*11] | Compound heterozygous | AR | Boute et al.17; Caridi et al.18 | |||
Patient 4 | NPHS2 c.[104insG]+[1143delC]; p.[Gly35Glyfs*35]+[Pro381Profs*5] | Compound heterozygous | AR | Boute et al.17; Berdeli et al.19 | |||
Patient 5 | NPHS2 c. [771C>T]+[911C>T]; p.[Arg229Gln]+[Ser304Phe] | Compound heterozygous | AR | Tsukaguchi et al.20 | Pos dam | Path | ++a |
Patient 6 | PLCE1 c.[4570_4571delAT]+[2277G>T]; p.[Met1524Alafs*5]+[Arg548Leu] | Compound heterozygous | AR | Prob dam | Path | +++b | |
Patient 7 | PLCE1 c.[2038C>T]+[4327G>A]; p.[Gln680*]+[Gly1443Arg] | Compound heterozygous | AR | Prob dam | Path | +++b | |
Patient 8 | ACTN4 c.[782C>A]+[=]; p.[Val261Glu]+[=] | Heterozygous | AD | Prob dam | Path | +++b | |
Patient 9 | ACTN4 c.[464T>C]+[=]; p.[Ile155Thr]+[=] | Heterozygous | AD | Prob dam | Neu | +++b | |
Patient 10 | LMX1B c.[833C>T]+[=]; p.[Ala278Val]+[=] | Heterozygous | AD | Prob dam | Path | +++b |